Netlist Inc: Form 10-Q for the period ended Jul 1, 2023
Filed with the SEC on Aug 8, 2023 and accepted by EDGAR at Aug 8, 2023, 20:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-02 to 2023-07-01 | $10.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2023-01-01 to 2023-07-01 | $19.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2023-04-02 to 2023-07-01 | $9.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-01-01 to 2023-07-01 | $18.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-04-02 to 2023-07-01 | $239.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-07-01 | $799.0k | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-02 to 2023-07-01 | $2.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-07-01 | $4.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-04-02 to 2023-07-01 | $3.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-01-01 to 2023-07-01 | $6.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-04-02 to 2023-07-01 | −$14.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-07-01 | −$30.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-02 to 2023-07-01 | $1.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-07-01 | $1.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-02 to 2023-07-01 | −$14.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-07-01 | −$29.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-02 to 2023-07-01 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-07-01 | −$0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-02 to 2023-07-01 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-07-01 | −$0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-02 to 2023-07-01 | 240,382,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-07-01 | 237,752,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-07-01 | −$28.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2023-07-01 | $24.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $43.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $47.0m | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $23.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $25.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-07-01 | $21.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-23-013975. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.